In vivo proof of concept

Self-assembling Nanofibril Particles for Controlled Release of IV and SUBQ Therapeutics

SUMMARY Clinically approved methods for the controlled release of oral therapies have demonstrated their efficacy in reducing required dosage, administration frequency, and side effects, thereby boosting patient compliance. Despite these successes, no solution is available for the controlled release of intravenously and subcutaneously administered therapies. The inventors synthesized copolymers composed… Read More

Doped Silicon Nanowires for the Selective Modulation of Single-cells

SUMMARY Electric stimulation of organs with implantable devices has demonstrated clinical utility for the treatment of a variety of diseases such as cardiac arrythmia. However, use of these technologies remains high risk, requiring either surgical implantation or permanent gene editing. The inventors synthesized silicon nanowires that are doped with gold… Read More